New drug can help stop certain breast cancer tumours early, trial shows
A trial called Serena-6 shows that camizestrant stops cancer cells from using hormones to grow, which helps patients stay well longer and delays the need for chemotherapy.
It is the first worldwide study to show that using blood tests to find early signs of cancer resistance to treatment helps patients, scientists say.
The study looked at patients who had hormone-positive, HER2-negative breast cancer, which is about 70% of cases.
Results showed patients given camizestrant reduced their chances of cancer progression by 56%, compared with just standard therapies.
Doctors used a simple blood test to spot changes in the cancer's DNA that show whether current treatments might soon stop working.
When they found these signs, some patients were given camizestrant, while others stayed on their usual treatment.
Those on camizestrant had their cancer stay the same and not get worse for much longer, 16 months on average, compared with about nine months for the others.
The drug was safe for most patients but 1% stopped taking it because of side effects.
More than 3,000 patients from 23 countries took part in the study, which was funded by AstraZeneca and co-led by researchers at The Institute of Cancer Research in London.
Co-principal investigator Professor Nick Turner, group leader in molecular oncology at The Institute of Cancer Research, London, said the drug is 'a pivotal moment in breast cancer care'.
Professor Kristian Helin, chief executive of The Institute of Cancer Research said: 'The results of the Serena-6 trial represent more than a clinical milestone, they represent a transformational shift in how we approach precision medicine.'
About 55,000 women are diagnosed with breast cancer in the UK every year and 11,500 will die from the disease, The Institute of Cancer Research said.
The Serena-6 trial results were to be presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on Sunday.
Dr Catherine Elliott, director of research at Cancer Research UK, said: 'This study is a clear example of how blood tests are starting to transform cancer treatment.
'By tracking tiny traces of tumour DNA in the blood, researchers were able to spot early signs of treatment resistance and switch therapies before cancer had a chance to grow.
'It shows how circulating tumour DNA, or ctDNA, could help doctors make smarter, more timely treatment decisions.
'This approach could become an important part of how we personalise care for people with advanced breast cancer.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
2 days ago
- The Sun
Sleep problem that affects 10million people in UK could trigger world's deadliest cancer, first-of-its-kind study warns
HEAVY snorers could be at risk of the world's deadliest cancer, a shock new study has revealed. Obstructive sleep apnea (OSA) has previously been linked to an increased risk of certain cancers. 1 Now, in a world-first trial, a "significant" link has been found between the condition and lung cancer. US researchers, who assessed the health records of more than 2.4 million adults, say they're not exactly sure why it raises the risk. But they believe it could be due to a lack of oxygen people with the condition get during the night - or lifestyle factors such as smoking and obesity. The findings were presented at the American Society of Clinical Oncology conference in Chicago. Scientists present urged policymakers to consider screening those with OSA for the cancer, and to tackle the condition early, soon after diagnosis. Globally, an estimated 936 million adults aged 30-69 years are affected by OSA. The condition occurs when the muscles in the throat relax too much during sleep, causing the airway to narrow or close, interrupting breathing. This can happen due to several factors, including obesity, a large neck or collar size, structural abnormalities like a small lower jaw or a large tongue, and other medical conditions. Common symptoms include breathing stopping and starting, making gasping, snorting or choking noises, waking up a lot, and loud snoring, says the NHS. According to the Sleep Apnoea Trust, as many as 10 million people in the UK suffer from OSA – with up to four million of these suffering either severely or moderately - although it's considered to be underdiagnosed. I'm a doctor and these 5 changes could be a sign of deadly lung cancer It's important to note while snoring is a common symptom of OSA, it's not a guaranteed sign. In the study, researchers at Marshall University in West Virginia tracked lung cancer diagnoses and separated those diagnosed with OSA and those without. After accounting for different influential factors, such as age, people with OSA were found to be 1.21 times more likely to develop lung cancer compared to those without the sleep disorder. Dr Jowan Al-Nusair, study co-author and physician at Marshall University told MailOnline it was "one of the first statistically significant studies" to prove a link between the condition and lung cancer. She added: "While further studies are definitely now needed to investigate just how the significant the link truly is, this suggests OSA may be a preventable risk factor for lung cancer. "We should be more closely monitoring patients with OSA. Patients would definitely benefit from screening and early intervention to combat OSA. "Additional studies are essential to understand exactly why OSA may increase this risk. "We really hope this will pave the way for future research and testing." Lung cancer is the leading cause of cancer deaths worldwide. In the UK, around 35,000 people die from lung cancer each year. The primary cause of lung cancer is tobacco smoke, accounting for the vast majority of cases. But lung cancer cases are now rising among young people who have never smoked, with some experts attributing this to factors like air pollution. Do you have obstructive sleep apnoea? Sleep apnoea is when your breathing stops and starts while you sleep. The most common type is called obstructive sleep apnoea (OSA). Sleep apnoea needs to be treated because it can lead to more serious problems. Symptoms mainly happen while you're asleep, they include: breathing stopping and starting making gasping, snorting or choking noises waking up a lot loud snoring During the day, you may also: feel very tired find it hard to concentrate have mood swings have a headache when you wake up It can be hard to tell if you have sleep apnoea. It may help to ask someone to stay with you while you sleep so they can check for the symptoms. If a GP thinks you might have sleep apnoea, they may refer you to a specialist sleep clinic for tests. Source: NHS
The Independent
2 days ago
- The Independent
The foods that colon cancer patients should avoid
A study of over 1,600 stage three colon cancer patients revealed that those who consumed proinflammatory foods like white bread, French fries, hot dogs, and soda had an 87 per cent higher risk of death compared to those with the least proinflammatory diet. Experts noted that these findings underscore the importance of diet and physical activity in colorectal cancer patient outcomes. The study, presented at the American Society of Clinical Oncology Annual Meeting, indicated that anti-inflammatory drugs did not significantly influence the diet-survival relationship, but higher physical activity levels correlated with better survival outcomes. Prior research also indicated that systemic inflammation can elevate the risk of colon cancer development. Experts recommend focusing on overall eating patterns, emphasising anti-inflammatory foods like dark leafy greens, vegetables, nuts, whole grains, and omega-3-rich protein.
NBC News
2 days ago
- NBC News
An anti-inflammatory diet may help colon cancer patients live longer, study says
Eating food that lowers inflammation in the body may help people with advanced colon cancer survive longer, according to research presented at a meeting of the American Society of Clinical Oncology in Chicago. The findings, presented Sunday, suggest that cancer patients can have at least some control over the outcome of their disease, even at later stages. 'This is the most common question that patients ask me when I see them in clinic,' said Dr. Kimmie Ng, an author of the new study and associate chief of the division of gastrointestinal oncology at Dana-Farber Cancer Institute in Boston. 'What is it that I can do myself to try to improve my chances, help me live as long as possible?' Ng's study — which has not yet been published in a peer-reviewed journal — looked at the diets of 1,625 adults with stage 3 colon cancer, meaning the cancer has spread to nearby lymph nodes, but not to other parts of the body. With standard care — surgery and chemotherapy in most cases — about three-quarters of patients can expect to live at least five years after their diagnosis, according to the American Cancer Society. The new research suggests diet may influence those odds. 'What's unique about colon cancer is that it's a cancer of the digestive tract,' said Dr. Sara Char, Ng's co-author and a clinical fellow in hematology and oncology at Dana-Farber Cancer Institute. 'What we eat will inevitably go through the colon.' All the patients in the new analysis got the same treatment: surgery, followed by three to six months of chemotherapy. They also filled out dietary questionnaires during and after their chemotherapy treatments. Researchers followed up on the participants for five years. Patients who regularly ate foods that promote inflammation in the body — ultraprocessed foods, excessive amounts of sugar and saturated fats — had up to an 87% higher risk of dying from their disease when compared to people who ate a far less inflammatory diet. The less-inflammatory diet was more plant-focused, and included foods such as leafy greens, carrots, coffee and tea. Real-world examples Cancer centers have dietitians who work with patients to make sure they're getting proper nutrition while they're going through treatment, said Heather Greenlee, medical director of integrative medicine at Fred Hutchinson Cancer Center in Seattle. Chemotherapy, for example, can come with side effects, including difficulty swallowing and poor appetite. Once treatment is done, patients may need additional help making dietary changes to improve survival long term. 'The issue that a lot of patients face is that people don't know how to make these dietary changes that are sustainable over time,' said Greenlee, who also wasn't involved with the research. Greenlee heads Fred Hutch's Cook for Your Life program for people who've had cancer. 'It's really important for big studies like this to be done to show that there is this potential benefit for lifestyle and behavioral changes in the face of some of these cancers that are difficult to treat,' she said. She recommends a plant-focused approach, such as adding beans, broccoli and cauliflower to meals, as well as high-fiber foods. 'Those are all good places to start,' Greenlee said. Exercise boost Patients also boosted their chances of living longer with physical activity. People who ate diets least likely to promote inflammation and who did the equivalent of taking a brisk walk for an hour at least three times a week had a 63% lower risk of death from any cause during the five-year follow-up period. A separate study, also presented Sunday at the cancer meeting, found that regular exercise was linked to a 28% lower risk of the cancer recurring, a new cancer diagnosis or death. More than 150,000 people are diagnosed with colorectal cancer every year, according to the American Cancer Society. 'Not only can healthy lifestyle choices, like diet and exercise, have an impact after a cancer diagnosis,' said Dr. Julie Gralow, chief medical officer of the American Society of Clinical Oncology, 'they are absolutely as good as the benefits we see from drugs, and probably even better.'
